This presents a remarkable opportunity to acquire a manufacturing unit producing a unique soap initially pioneered by Kimberly Clark. Positioned at the forefront of revolutionizing surgical hygiene, this soap offers a revolutionary container and dispenser system tailored for healthcare setups demanding stringent aseptic conditions.
This exceptional soap represents a significant advancement in maintaining aseptic environments within operating rooms. The acquisition encompasses all blow molding, injection molds, and associated equipment for fabricating these pioneering products.
In 2007, a consortium of Latin American entrepreneurs acquired the foam-dispensed soap manufacturing unit from Kimberly Clark, envisioning expansion into Latin American markets. However, the project faced significant hurdles due to prolonged delays in securing FDA licensing for the newly formed corporation, compelling the company to rely solely on the Latin American market for several years. Fortunately, in January 2022, the company successfully obtained the required licenses and permissions to re-enter the American market.
Upon acquiring Kimberly Clark’s assets, the company initially maintained annual sales of over $4,500,000. Sales declined due to the lack of FDA approval for US distribution until 2022 when clearance was obtained. From 2007 to 2023, sales focused on Latin America, resulting in a loss of US and European accounts. The opportunity is to regain these markets and surpass 2007 sales, hindered only by insufficient working capital for immediate expansion.
The seller is open to two options: either selling the entire operation and equipment (Equipment and inventory valued at above $400,000) and assisting the buyer in reclaiming local accounts to restore revenue levels similar to those under Kimberly Clark ownership in 2007 or partnering with a buyer who can invest in working capital to propel the business to the next level.

Contact Tom Jones 754-224-3111 refer to 1206-00424 when inquiring.